The study includes adults with advanced or metastatic cancers that exhibit mutations in the B-Raf proto-oncogene, serine/threonine-protein kinase (BRAF), CRAF or neuroblastoma RAS viral oncogene ...

Servier and Black Diamond Therapeutics have signed a licensing agreement for a targeted therapy, BDTX-4933, to treat solid tumours. Servier will be responsible for the development and the global ...

Verastem (NASDAQ:VSTM – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both small-cap medical ...

KRAS, an oncogene that is mutated in around 20% of tumours, is a major cancer conundrum. For decades, researchers thought that it was too smooth to drug, until a team found a hidden toehold on one ...

Following Amgen and Mirati Therapeutics' recent clinical progressions, often viewed as the most promising breakthroughs targeting the cancer “master switch’, a tremendous amount of interest ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...

What Is Medullary Carcinoma Thyroid (MTC)? Medullary carcinoma is a rare type of cancer that can appear in different parts of the body. It most commonly shows up in the thyroid gland and the colon.

Few places blend raw natural beauty with ambition quite like Ras Al Khaimah‭. ‬Along its 64km coastline‭, ‬the Arabian Gulf stretches‭ ‬in sweeping turquoise‭, ‬lapping against ...